Models of Neurotoxicity: Extrapolation of Benchmark Doses in Vitro

Matteo Goldoni, Maria Vittoria Vettori, Rossella Alinovi, Andrea Caglieri, Sandra Ceccatelli and Antonio Mutti

Risk Analysis, 2003, vol. 23, issue 3, 505-514

Abstract: In risk assessment, no observed exposure level (NOAEL) and benchmark dose (BMD) are usually derived either from epidemiological studies in humans or from animal experiments. In many in vitro studies, concentration‐effect/response curves have been analyzed using different mathematical models finalized to the identification of EC50. In the present article, we propose a model to fit dose‐response curves in vitro. The BMD approach has been used to compare the cell viability (MTT assay) of different rat (C6 and PC12, glial and neuronal, respectively) and human cell lines (D384 and SK‐N‐MC, glial and neuronal, respectively) after 24‐hour exposure to the following neurotoxic substances: manganese chloride (MnCl2), methyl‐mercury (Me‐Hg), and the enantiomers of styrene oxide (SO). For all rat and human cell lines, the potency of the examined compounds was: MnCl2

Date: 2003
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1111/1539-6924.00331

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wly:riskan:v:23:y:2003:i:3:p:505-514

Access Statistics for this article

More articles in Risk Analysis from John Wiley & Sons
Bibliographic data for series maintained by Wiley Content Delivery ().